• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

残余肾功能和不同充分性指标对血液透析患者生存的相对贡献:荷兰透析充分性合作研究(NECOSAD)-2分析

Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2.

作者信息

Termorshuizen Fabian, Dekker Friedo W, van Manen Jeannette G, Korevaar Johanna C, Boeschoten Elisabeth W, Krediet Raymond T

机构信息

Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands.

出版信息

J Am Soc Nephrol. 2004 Apr;15(4):1061-70. doi: 10.1097/01.asn.0000117976.29592.93.

DOI:10.1097/01.asn.0000117976.29592.93
PMID:15034110
Abstract

A high delivered Kt/V(urea) (dKt/V(urea)) is advocated in the U.S. National Kidney Foundation Dialysis Outcomes Quality Initiative guidelines on hemodialysis (HD) adequacy, irrespective of the presence of residual renal function. The contribution of treatment adequacy and residual renal function to patient survival was investigated. The Netherlands Cooperative Study on the Adequacy of Dialysis is a prospective multicenter study that includes incident ESRD patients older than 18 yr. The longitudinal data on residual renal function and dialysis adequacy of patients who were treated with HD 3 mo after the initiation of dialysis (n = 740) were analyzed. The mean renal Kt/V(urea) (rKt/V(urea)) at 3 mo was 0.7/wk (SD 0.6) and the dKt/V(urea) at 3 mo was 2.7/wk (SD 0.8). Both components of urea clearance were associated with a better survival (for each increase of 1/wk in rKt/V(urea), relative risk of death = 0.44 [P < 0.0001]; dKt/V(urea), relative risk of death = 0.76 [P < 0.01]). However, the effect of dKt/V(urea) on mortality was strongly dependent on the presence of rKt/V(urea), low values for dKt/V(urea) of <2.9/wk being associated with a significantly higher mortality in anuric patients only. Furthermore, an excess of ultrafiltration in relation to interdialytic weight gain was associated with an increase in mortality independent of dKt/V(urea). In conclusion, residual renal clearance seems to be an important predictor of survival in HD patients, and the dKt/V(urea) should be tuned appropriately to the presence of renal function. Further studies are required to substantiate the important role of fluid balance in HD adequacy.

摘要

在美国国家肾脏基金会透析预后质量倡议关于血液透析(HD)充分性的指南中,提倡较高的透析尿素清除率(dKt/V(urea)),无论患者是否存在残余肾功能。本研究调查了治疗充分性和残余肾功能对患者生存的影响。荷兰透析充分性合作研究是一项前瞻性多中心研究,纳入了年龄超过18岁的新发终末期肾病(ESRD)患者。分析了透析开始3个月后接受HD治疗患者(n = 740)的残余肾功能和透析充分性的纵向数据。3个月时的平均肾脏Kt/V(urea)(rKt/V(urea))为0.7/周(标准差0.6),3个月时的dKt/V(urea)为2.7/周(标准差0.8)。尿素清除的两个组成部分均与更好的生存相关(rKt/V(urea)每增加1/周,死亡相对风险 = 0.44 [P < 0.0001];dKt/V(urea),死亡相对风险 = 0.76 [P < 0.01])。然而,dKt/V(urea)对死亡率的影响强烈依赖于rKt/V(urea)的存在,仅在无尿患者中,dKt/V(urea) <2.9/周的低值与显著更高的死亡率相关。此外,相对于透析间期体重增加的超滤过量与独立于dKt/V(urea)的死亡率增加相关。总之,残余肾清除似乎是HD患者生存的重要预测因素,dKt/V(urea)应根据肾功能的存在情况进行适当调整。需要进一步研究来证实液体平衡在HD充分性中的重要作用。

相似文献

1
Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2.残余肾功能和不同充分性指标对血液透析患者生存的相对贡献:荷兰透析充分性合作研究(NECOSAD)-2分析
J Am Soc Nephrol. 2004 Apr;15(4):1061-70. doi: 10.1097/01.asn.0000117976.29592.93.
2
The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2.残余肾功能与腹膜清除率对患者生存和生活质量的相对重要性:荷兰透析充分性合作研究(NECOSAD)-2分析
Am J Kidney Dis. 2003 Jun;41(6):1293-302. doi: 10.1016/s0272-6386(03)00362-7.
3
Time trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands.荷兰终末期肾病患者透析起始时间和剂量的时间趋势。
Nephrol Dial Transplant. 2003 Mar;18(3):552-8. doi: 10.1093/ndt/18.3.552.
4
Predictors of survival in anuric peritoneal dialysis patients.无尿腹膜透析患者的生存预测因素。
Kidney Int. 2005 Sep;68(3):1199-205. doi: 10.1111/j.1523-1755.2005.00512.x.
5
Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.新透析患者的递增式血液透析、残余肾功能与死亡风险:一项队列研究
Am J Kidney Dis. 2016 Aug;68(2):256-265. doi: 10.1053/j.ajkd.2016.01.008. Epub 2016 Feb 9.
6
Peritoneal dialysis adequacy and risk of death.腹膜透析充分性与死亡风险
Kidney Int. 2000 Jul;58(1):446-57. doi: 10.1046/j.1523-1755.2000.00184.x.
7
Chronic renal replacement therapy in children: which index is best for adequacy?儿童慢性肾脏替代治疗:哪种指标最能评估充分性?
Kidney Int. 1998 Nov;54(5):1690-6. doi: 10.1046/j.1523-1755.1998.00135.x.
8
Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function.美国腹膜透析患者早期死亡的危险因素:残余肾功能的影响。
Perit Dial Int. 2002 May-Jun;22(3):371-9.
9
[The equivalent renal urea clearance. Its relationship with mortality in chronic hemodialysed patients].[等效肾脏尿素清除率。其与慢性血液透析患者死亡率的关系]
Medicina (B Aires). 1999;59(4):348-50.
10
Adequacy in dialysis: intermittent versus continuous therapies.透析充分性:间歇性与连续性治疗
Nefrologia. 2000;20 Suppl 3:25-32.

引用本文的文献

1
BioImpedance Spectroscopy to maintain Renal Output: the BISTRO randomised controlled trial.生物电阻抗光谱法维持肾输出量:BISTRO随机对照试验
Health Technol Assess. 2025 Jul;29(32):1-23. doi: 10.3310/RHON2378.
2
Effectiveness of blood volume change-guided ultrafiltration control (BV-UFC) in hemodialysis: a crossover comparative study.血液容量变化引导的超滤控制(BV-UFC)在血液透析中的有效性:一项交叉对照研究。
Clin Kidney J. 2025 May 6;18(5):sfaf141. doi: 10.1093/ckj/sfaf141. eCollection 2025 May.
3
High level of soluble tumor necrosis factor receptors is associated with lower residual diuresis volume in patients on hemodialysis: An exploratory study.
血液透析患者中高水平可溶性肿瘤坏死因子受体与较低残余尿量相关:一项探索性研究。
PLoS One. 2025 Apr 29;20(4):e0320019. doi: 10.1371/journal.pone.0320019. eCollection 2025.
4
Volume Assessment in Patients Undergoing Long-Term Dialysis.长期透析患者的容量评估
J Am Soc Nephrol. 2025 Jun 1;36(6):1184-1196. doi: 10.1681/ASN.0000000724. Epub 2025 Apr 7.
5
Public and patient involvement (PPI) in the design, execution and dissemination of a trial: the BISTRO trial.公众和患者参与(PPI)在一项试验的设计、实施和传播中的应用:BISTRO试验
Health Technol Assess. 2025 Jan 29:1-18. doi: 10.3310/DOTR5903.
6
Impact of the Preservation of Residual Kidney Function on Hemodialysis Survival: Results from the BISTRO Trial.残余肾功能的保留对血液透析患者生存的影响:BISTRO试验结果
Kidney360. 2025 Jan 1;6(1):112-120. doi: 10.34067/KID.0000000596. Epub 2024 Oct 10.
7
Cost-effectiveness of bioimpedance-guided fluid management in patients undergoing haemodialysis: the BISTRO RCT.血液透析患者生物阻抗引导下的液体管理的成本效益:BISTRO随机对照试验
Health Technol Assess. 2024 Sep 25:1-45. doi: 10.3310/JYPR4287.
8
Twice Weekly versus Thrice Weekly Hemodialysis-A Pilot Cross-Over Equivalence Trial.每周两次与每周三次血液透析——一项交叉等效性试验的初步研究
Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1159-1168. doi: 10.2215/CJN.0000000000000507. Epub 2024 Jun 26.
9
Integrated home dialysis model: facilitating home-to-home transition.综合家庭透析模式:促进家庭间的过渡。
Clin Kidney J. 2024 Jun 5;17(Suppl 1):i21-i33. doi: 10.1093/ckj/sfae079. eCollection 2024 May.
10
Influencing factors for residual kidney function in incident peritoneal dialysis patients: a systematic review and meta-analysis.影响新进入腹膜透析患者残余肾功能的因素:系统评价和荟萃分析。
Ren Fail. 2023;45(2):2286328. doi: 10.1080/0886022X.2023.2286328. Epub 2023 Nov 30.